Article

Patients Play an Important Role in Cancer Treatment

While it is the responsibility of the clinician to inform their patients of all options available, it is, in turn, vital for them to play a role in selecting the cancer treatment that’s right for them, according to Dr. Sara Hurvitz.

While it is the responsibility of the clinician to inform their patients of all options available, it is, in turn, vital for them to play a role in selecting the cancer treatment that’s right for them, according to Dr. Sara Hurvitz.

In an interview with CURE, Hurvitz, an associate professor of medicine at the University of California, Los Angeles, explained how doctors may educate and recommend various treatment options, but ultimately, patients are the ones who need to weigh their options and decide on the best course of therapy.

Transcript:

In my opinion, it’s imperative and ethical to have patients play a role in all of the treatment decisions. These are the people who are going to be assuming all of the toxicity and side effects — and the benefits, frankly – of a given therapy.

We as clinicians, it’s my opinion, that we need to educate our patients and empower them to help them make a decision. It’s certainly our responsibility as clinicians to make a recommendation for the treatment that has the best therapeutic index, meaning highest efficacy and lowest toxicity. But ultimately, the patient is the one that needs to buy in and decide which therapy they would like to proceed with.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Watch oncology dietitian Kenisha Parikh prepare creamy lentil soup, a soothing, protein-packed recipe to help ease side effects during treatment.
Related Content